feasibility of implant placement in patients with osteonecrosis of the jaw using a new surface-treated implant: a single-group prospective exploratory clinical trial
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0009654
- Lead Sponsor
- Ewha Womans University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
? Adult patients whose age is over 19 years of age and whose jaw growth has been completed
? If you have or have been given a medication that can cause jaw necrosis:IV Bisphosphonate, Denosumab, Angiogenesis inhibitor, etc.Oral use for more than 2 years have been diagnosed with osteonecrosis of the jaw amd have undergone bone resection surgery, then 6 months after complete recovery
? Patients who agreed to participate in the clinical trial and signed the patient consent form
? If there is a history of radiation therapy in the head and neck, including jaw, or a malignant tumor of the jaw area
? Patients who unctrolled systemic disease, including hemorrhagic diseases
? Patients who have hypersensitivity to implant, metal plate materials, or implant materials
? Patients requiring extensive bone grafting
? Patients who have severe oral and jaw habits(bruxism, clenching)
? If the investigator determines that participation in the clinical trial is inappropriate because it may affect other ethical or clinical trial results.
? Patients who find implant placement surgery difficult (uncooperative patients, cases with very poor oral hygiene management, etc.)
? Patients who do not understand the purpose of the research and do not agree
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method